Clinical Trial Update: Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer

View source ↗

Summary

A prospective comparative study evaluating two hypofractionated adjuvant radiotherapy schedules (2 weeks versus 3 weeks) for breast cancer; the trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Salwa Shawky Bakeet Ali | Conditions: Breast Cancer | Status: NOT_YET_RECRUITING